JPH07502253A - St1435の治療有効局所施用 - Google Patents
St1435の治療有効局所施用Info
- Publication number
- JPH07502253A JPH07502253A JP3511213A JP51121391A JPH07502253A JP H07502253 A JPH07502253 A JP H07502253A JP 3511213 A JP3511213 A JP 3511213A JP 51121391 A JP51121391 A JP 51121391A JP H07502253 A JPH07502253 A JP H07502253A
- Authority
- JP
- Japan
- Prior art keywords
- vehicle
- skin
- composition
- progesterone
- levels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims (17)
- 1.化合物16−メチレン−17α−アセトキシ−19−ノル−4−プレグネン −3,20−ジオンの投与方法であって、医薬的に許容されるビヒクル中の治療 有効量の上記化合物を皮膚に局所施用することからなる投与方法。
- 2.上記ビヒクルが皮膚を閉塞するものではない、請求項1に記載の方法。
- 3.上記医薬的に許容されるビヒクルが液体、半固体および固体からなる群から 選ばれる、請求項1に記載の方法。
- 4.上記ビヒクルが軟膏、クリーム、リンス液およびゲルからなる群から選ばれ る、請求項1に記載の方法。
- 5.上記ビヒクルがバンド、ディスク、パッチおよび輪帯からなる群から選ばれ る、請求項1に記載の方法。
- 6.上記16−メチレン−17α−アセトキシ−19−ノル−4−プレグネン− 3,20−ジオンが少なくとも約50pmol/リットルの血清濃度を得るのに 充分な量で、医薬的に許容されるビヒクル中に存在する、請求項1に記載の方法 。
- 7.上記16−メチレン−17α−アセトキシ−19−ノル−4−プレグネン− 3,20−ジオンが避妊薬として作用する、請求項1に記載の方法。
- 8.上記化合物が、ホルモン類、ホルモン類縁体およびホルモン誘導体からなる 群から選ばれる少なくとも1種の追加の成分の治療有効量と混合されている、請 求項1に記載の方法。
- 9.上記追加の成分がエストロゲンである、請求項7に記載の方法。
- 10.治療有効量の16−メチレン−17α−アセトキシ−19−ノル−4−プ レグネン−3,20−ジオンを医薬的に許容されるビヒクル中に含有する局所施 用用組成物。
- 11.上記ビヒクルが液体、半固体および固体からなる群から選はれる、請求項 9に記載の組成物。
- 12.上記ビヒクルが皮膚を閉塞するものではない、請求項9に記載の組成物。
- 13.上記ビヒクルが軟膏、クリーム、リンス液およびゲルからなる群から選ば れる、請求項9に記載の組成物。
- 14.上記ビヒクルが、バンド、ディスク、パッチおよび輪帯からなる群から選 ばれる経皮用具である、請求項9に記載の組成物。
- 15.上記16−メチレン−17α−アセトキシ−19−ノル−4−ブレグネン −3,20−ジオンが少なくとも約50pmol/リットルの血清濃度を得るの に充分な量で、医薬的に許容されるビヒクル中に存在する、請求項9に記載の組 成物。
- 16.ホルモン類、ホルモン類縁体およびホルモン誘導体からなる群から選ばれ る少なくとも1種の追加の成分の治療有効量をさらに含有する、請求項9に記載 の組成物。
- 17.上記追加の成分がエストロゲンである、請求項14に記載の組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53221590A | 1990-06-01 | 1990-06-01 | |
US532,215 | 1990-06-01 | ||
PCT/US1991/003697 WO1991018570A1 (en) | 1990-06-01 | 1991-05-24 | Therapeutically effective topical application of st1435 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07502253A true JPH07502253A (ja) | 1995-03-09 |
JP2625254B2 JP2625254B2 (ja) | 1997-07-02 |
Family
ID=24120850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3511213A Expired - Lifetime JP2625254B2 (ja) | 1990-06-01 | 1991-05-24 | St1435の治療有効局所施用 |
Country Status (10)
Country | Link |
---|---|
US (1) | US5651973A (ja) |
EP (3) | EP0600873B1 (ja) |
JP (1) | JP2625254B2 (ja) |
AT (2) | ATE220912T1 (ja) |
CA (1) | CA2083404C (ja) |
DE (2) | DE69133077T2 (ja) |
DK (2) | DK0754456T3 (ja) |
ES (2) | ES2099747T3 (ja) |
GR (1) | GR3023312T3 (ja) |
WO (1) | WO1991018570A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9682087B2 (en) | 2009-12-17 | 2017-06-20 | The Population Council, Inc. | Nestorone®/estradiol transdermal gel |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991018570A1 (en) * | 1990-06-01 | 1991-12-12 | Robertson, Dale, N. | Therapeutically effective topical application of st1435 |
US6197327B1 (en) | 1997-06-11 | 2001-03-06 | Umd, Inc. | Device and method for treatment of dysmenorrhea |
FR2776191B1 (fr) * | 1998-03-23 | 2002-05-31 | Theramex | Composition hormonale topique a effet systemique |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US8529807B2 (en) * | 2002-01-17 | 2013-09-10 | Lts Lohmann Therapie-Systeme Ag | Method for neutralizing or recycling carrier materials for film-like coatings |
GB2389793A (en) * | 2002-06-18 | 2003-12-24 | Euro Celtique Sa | Transdermal delivery system |
US20040057983A1 (en) | 2002-09-25 | 2004-03-25 | David Schmidt | Biomolecular wearable apparatus |
CN101287470B (zh) | 2005-10-12 | 2012-10-17 | 优尼麦德药物股份有限公司 | 改良的睾酮凝胶及使用方法 |
US8602961B2 (en) | 2008-05-15 | 2013-12-10 | Lifewave Products Llc | Apparatus and method of stimulating elevation of glutathione levels in a subject |
US20110220817A1 (en) * | 2008-08-12 | 2011-09-15 | Moore John W | Method of reducing the distortion of the electromagnetic field |
US10322063B2 (en) | 2013-03-19 | 2019-06-18 | Genovus Biotechnologies Inc. | Muscle optimization device and method |
US10888707B2 (en) | 2013-03-19 | 2021-01-12 | Genovus Biotechnologies Inc. | Muscle optimization device and method |
MX2017006207A (es) | 2014-11-25 | 2017-07-31 | Buckman Laboratories Int Inc | Acondicionador y limpiador de fieltro. |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4292965A (en) * | 1978-12-29 | 1981-10-06 | The Population Council, Inc. | Intravaginal ring |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1543245C3 (de) * | 1965-11-26 | 1974-07-18 | Merck Patent Gmbh, 6100 Darmstadt | 16-Methy len-19-norprogesteronderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen |
NL6902314A (ja) * | 1969-02-13 | 1970-08-17 | ||
US3854480A (en) * | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
US3948262A (en) * | 1969-04-01 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
US4144317A (en) * | 1975-05-30 | 1979-03-13 | Alza Corporation | Device consisting of copolymer having acetoxy groups for delivering drugs |
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
US4834978A (en) * | 1984-10-01 | 1989-05-30 | Biotek, Inc. | Method of transdermal drug delivery |
US4818540A (en) * | 1985-02-25 | 1989-04-04 | Rutgers, The State University Of New Jersey | Transdermal fertility control system and process |
AU607172B2 (en) * | 1986-12-22 | 1991-02-28 | Cygnus, Inc. | Diffusion matrix for transdermal drug administration |
CH674618A5 (ja) * | 1987-04-02 | 1990-06-29 | Ciba Geigy Ag | |
EP0370220B1 (de) * | 1988-10-27 | 1996-01-10 | Schering Aktiengesellschaft | Mittel zur transdermalen Applikation enthaltend Gestoden |
WO1991018570A1 (en) * | 1990-06-01 | 1991-12-12 | Robertson, Dale, N. | Therapeutically effective topical application of st1435 |
WO1991018572A1 (en) * | 1990-06-01 | 1991-12-12 | Robertson, Dale, N. | Device for transdermal administration of drugs |
US5122382A (en) * | 1990-10-29 | 1992-06-16 | Alza Corporation | Transdermal contraceptive formulations, methods and devices |
-
1991
- 1991-05-24 WO PCT/US1991/003697 patent/WO1991018570A1/en active IP Right Grant
- 1991-05-24 AT AT96201585T patent/ATE220912T1/de not_active IP Right Cessation
- 1991-05-24 ES ES91912052T patent/ES2099747T3/es not_active Expired - Lifetime
- 1991-05-24 EP EP91912052A patent/EP0600873B1/en not_active Expired - Lifetime
- 1991-05-24 EP EP99202044A patent/EP1093816A3/en not_active Withdrawn
- 1991-05-24 AT AT91912052T patent/ATE151977T1/de not_active IP Right Cessation
- 1991-05-24 DE DE69133077T patent/DE69133077T2/de not_active Expired - Lifetime
- 1991-05-24 ES ES96201585T patent/ES2180690T3/es not_active Expired - Lifetime
- 1991-05-24 DK DK96201585T patent/DK0754456T3/da active
- 1991-05-24 JP JP3511213A patent/JP2625254B2/ja not_active Expired - Lifetime
- 1991-05-24 DK DK91912052.7T patent/DK0600873T3/da active
- 1991-05-24 CA CA002083404A patent/CA2083404C/en not_active Expired - Lifetime
- 1991-05-24 US US07/952,867 patent/US5651973A/en not_active Expired - Lifetime
- 1991-05-24 DE DE69125855T patent/DE69125855T2/de not_active Expired - Lifetime
- 1991-05-24 EP EP96201585A patent/EP0754456B1/en not_active Expired - Lifetime
-
1997
- 1997-05-02 GR GR970400968T patent/GR3023312T3/el unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4292965A (en) * | 1978-12-29 | 1981-10-06 | The Population Council, Inc. | Intravaginal ring |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9682087B2 (en) | 2009-12-17 | 2017-06-20 | The Population Council, Inc. | Nestorone®/estradiol transdermal gel |
Also Published As
Publication number | Publication date |
---|---|
DE69133077D1 (de) | 2002-08-29 |
WO1991018570A1 (en) | 1991-12-12 |
DE69133077T2 (de) | 2002-11-07 |
JP2625254B2 (ja) | 1997-07-02 |
EP0600873B1 (en) | 1997-04-23 |
DK0754456T3 (da) | 2002-11-11 |
US5651973A (en) | 1997-07-29 |
DE69125855D1 (de) | 1997-05-28 |
CA2083404A1 (en) | 1991-12-02 |
ATE220912T1 (de) | 2002-08-15 |
EP0600873A1 (en) | 1994-06-15 |
EP0754456B1 (en) | 2002-07-24 |
ES2099747T3 (es) | 1997-06-01 |
GR3023312T3 (en) | 1997-08-29 |
EP0754456A3 (en) | 2000-02-02 |
ES2180690T3 (es) | 2003-02-16 |
EP0600873A4 (en) | 1993-09-02 |
ATE151977T1 (de) | 1997-05-15 |
DE69125855T2 (de) | 1997-07-31 |
EP1093816A3 (en) | 2003-10-22 |
EP0754456A2 (en) | 1997-01-22 |
CA2083404C (en) | 2001-02-20 |
EP1093816A2 (en) | 2001-04-25 |
DK0600873T3 (da) | 1997-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2004253593B2 (en) | Transdermal hormone delivery system: compositions and methods | |
US5422119A (en) | Transdermal hormone replacement therapy | |
CA2256365A1 (en) | Compositions, methods and devices for the transdermal delivery of drugs | |
JPH07502253A (ja) | St1435の治療有効局所施用 | |
JP2009512658A (ja) | 予防用要求次第ホルモン避妊方法 | |
MXPA00012304A (es) | Composiciones farmaceuticas y usos para el androst-5-ene-3beta, 17 beta-diol. | |
EP1485103A1 (en) | Sulfatase inhibiting continuous progestogen contraceptive regimens | |
Nachtigall | Emerging delivery systems for estrogen replacement: aspects of transdermal and oral delivery | |
Smith et al. | Postmenopausal hormone therapy—local and systemic: a pharmacologic perspective | |
Jewelewicz | New developments in topical estrogen therapy | |
Sitruk-Ware | Transdermal application of steroid hormones for contraception | |
JP3043071B2 (ja) | エストロゲンを含む経皮的投与装置 | |
EP1613293A1 (en) | Extended transdermal contraceptive regimens | |
Ibarra de Palacios et al. | Comparative study to evaluate skin irritation and adhesion of Estradot® and Climara® in healthy postmenopausal women | |
US20040062794A1 (en) | 17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy | |
Baracat et al. | Comparative bioavailability study of a matrix versus a reservoir transdermal estradiol patch in healthy postmenopausal women | |
HU218290B (en) | Process for producing pharmaceutical compositions containing estriol which are applicable for treatment of climacteric osteoporosis | |
EP1482947A1 (en) | Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens | |
Simon | Estrogen pharmacokinetics: interindividual variations | |
Burry | Topical progesterone | |
Raynaud et al. | Comparison of the efficacy and tolerability of a new once-a-week matricial estradiol transdermal system (Estrapatch® 40 and Estrapatch® 60) with a twice week system | |
Schneider | The Role of Antiandrogens in Peri-and Postmenopausal HRT | |
Wattanakumtornkul et al. | Nasal Administration: In reply |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090411 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090411 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100411 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110411 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120411 Year of fee payment: 15 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120411 Year of fee payment: 15 |